A consortium focused on enhancing cancer clinical trials in the Deep South.
NCTN Deep South Research Consortium
This study is working to make cancer clinical trials better by encouraging more people, especially from the Southeastern U.S. and diverse backgrounds, to join in, so that everyone can benefit from new treatments and research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10794230 on NIH RePORTER |
What this research studies
The NCTN Deep South Research Consortium aims to improve cancer clinical trials by increasing participation from eligible patients, particularly in the Southeastern United States. This initiative focuses on enhancing the involvement of scientific leaders and developing future leaders in cancer research. The consortium also emphasizes the importance of increasing minority participation in clinical trials to ensure diverse representation. By refining the clinical trials process, the consortium seeks to optimize patient accrual and improve outcomes for those at risk for cancer.
Who could benefit from this research
Good fit: Ideal candidates for participation include cancer patients and individuals at risk for cancer residing in the Southeastern United States.
Not a fit: Patients who do not reside in the Southeastern United States or those not diagnosed with cancer or at risk for cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and improved access to clinical trials for patients in the Deep South.
How similar studies have performed: Previous research has shown success in increasing clinical trial participation through targeted outreach and community engagement, making this approach promising.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Leath, Charles a. — University of Alabama at Birmingham
- Study coordinator: Leath, Charles a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.